Your browser doesn't support javascript.
loading
T-cell receptor excision circle levels and safety of paediatric immunization: A population-based self-controlled case series analysis.
Wilson, Kumanan; Duque, Daniel Rodriguez; Murphy, Malia S Q; Hawken, Steven; Pham-Huy, Anne; Kwong, Jeffrey; Deeks, Shelley L; Potter, Beth K; Crowcroft, Natasha S; Bulman, Dennis E; Chakraborty, Pranesh; Little, Julian.
Affiliation
  • Wilson K; a Clinical Epidemiology Program, Ottawa Hospital Research Institute , Ottawa , Canada.
  • Duque DR; b School of Epidemiology and Public Health, University of Ottawa , Ottawa , Canada.
  • Murphy MSQ; c Institute for Clinical Evaluative Sciences, University of Ottawa , Ottawa , Canada.
  • Hawken S; a Clinical Epidemiology Program, Ottawa Hospital Research Institute , Ottawa , Canada.
  • Pham-Huy A; a Clinical Epidemiology Program, Ottawa Hospital Research Institute , Ottawa , Canada.
  • Kwong J; b School of Epidemiology and Public Health, University of Ottawa , Ottawa , Canada.
  • Deeks SL; d Department of Pediatrics , University of Ottawa , Ottawa , Canada.
  • Potter BK; e Dalla Lana School of Public Health, University of Toronto , Toronto , Canada.
  • Crowcroft NS; e Dalla Lana School of Public Health, University of Toronto , Toronto , Canada.
  • Bulman DE; b School of Epidemiology and Public Health, University of Ottawa , Ottawa , Canada.
  • Chakraborty P; e Dalla Lana School of Public Health, University of Toronto , Toronto , Canada.
  • Little J; d Department of Pediatrics , University of Ottawa , Ottawa , Canada.
Hum Vaccin Immunother ; 14(6): 1378-1391, 2018 06 03.
Article in En | MEDLINE | ID: mdl-29420131
T-cell receptor excision circle levels are a surrogate marker of T-cell production and immune system function. We sought to determine whether non-pathological levels of infant T-cell receptor excision circles were associated with adverse events following immunization. A self-controlled case series design was applied on a sample of 231,693 children who completed newborn screening for severe combined immunodeficiency in Ontario, Canada between August 2013 and December 2015. Exposures included routinely administered pediatric vaccines up to 15 months of age. Main outcomes were combined health services utilization for recognized adverse events following immunization. 1,406,981 vaccination events were included in the final dataset. 103,007 children received the Pneu-C-13 or Men-C-C vaccine and 97,998 received the MMR vaccine at 12 months of age. 67,725 children received the varicella immunization at 15 months. Our analysis identified no association between newborn T-cell receptor excision circle levels and subsequent health services utilization events following DTa-IPV-Hib, Pneu-C-13, and Men-C-C vaccinations at 2-month (RI 0.94[95%CI 0.87-1.02]), 4-month (RI 0.82[95%CI 0.75-0.9]), 6-month (RI 0.63[95%CI 0.57-0.7]) and 12-month (RI 0.49[95%CI 0.44-0.55]). We also found no trends in health services utilization following MMR (RI 1.43[95%1.34-1.52]) or varicella (RI 1.14[95%CI 1.05-1.23]) vaccination. Our findings provide further support for the safety of pediatric vaccinations.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Circular / Vaccines / Receptors, Antigen, T-Cell / Drug-Related Side Effects and Adverse Reactions Type of study: Prognostic_studies Limits: Female / Humans / Infant / Male / Newborn Country/Region as subject: America do norte Language: En Journal: Hum Vaccin Immunother Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Circular / Vaccines / Receptors, Antigen, T-Cell / Drug-Related Side Effects and Adverse Reactions Type of study: Prognostic_studies Limits: Female / Humans / Infant / Male / Newborn Country/Region as subject: America do norte Language: En Journal: Hum Vaccin Immunother Year: 2018 Document type: Article Affiliation country: Country of publication: